Tibetan mesenchymal stem cell-derived exosomes alleviate pulmonary vascular remodeling in hypoxic pulmonary hypertension rats
Authors:
- 8 May 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 42 (8) , 720-735
Abstract
Hypoxic pulmonary hypertension (HPH) is characterized by progressive pulmonary vasoconstriction, vascular remodeling, and right ventricular hypertrophy, causing right heart failure. This study aimed to investigate the therapeutic effects of exosomes from Tibetan umbilical cord mesenchymal stem cells on HPH via the TGF-β1/Smad2/3 pathway, comparing them with exosomes from Han Chinese individuals. An HPH rat model was established in vivo, and a hypoxia-induced injury in the rat pulmonary artery smooth muscle cells (rPASMCs) was simulated in vitro. Exosomes from human umbilical cord mesenchymal stem cells were administered to HPH model rats or added to cultured rPASMCs. The therapeutic effects of Tibetan-mesenchymal stem cell-derived exosomes (Tibetan-MSC-exo) and Han-mesenchymal stem cell-derived exosomes (Han-MSC-exo) on HPH were investigated through immunohistochemistry, Western blotting, EdU, and Transwell assays. The results showed that Tibetan-MSC-exo significantly attenuated pulmonary vascular remodeling and right ventricular hypertrophy in HPH rats compared with Han-MSC-exo. Tibetan-MSC-exo demonstrated better inhibition of hypoxia-induced rPASMCs proliferation and migration. Transcriptome sequencing revealed upregulated genes (Nbl1, Id2, Smad6, and Ltbp1) related to the TGFβ pathway. Nbl1 knockdown enhanced hypoxia-induced rPASMCs proliferation and migration, reversing Tibetan-MSC-exo-induced downregulation of TGFβ1 and p-Smad2/3. Furthermore, TGFβ1 overexpression hindered the therapeutic effects of Tibetan-MSC-exo and Han-MSC-exo on hypoxic injury. These findings suggest that Tibetan-MSC-exo favors HPH treatment better than Han-MSC-exo, possibly through the modulation of the TGFβ1/Smad2/3 pathway via Nbl1.Keywords
Funding Information
- National Natural Science Foundation of China (32060207)
- Qinghai Provincial Department of Science and Technology Project (2021-ZJ-738)
- Qinghai University (No.2022-KF-03)
This publication has 26 references indexed in Scilit:
- A pleiotropic hypoxia-sensitive EPAS1 enhancer is disrupted by adaptive alleles in TibetansScience Advances, 2022
- Function and regulation of transforming growth factor β1 signalling in antler chondrocyte proliferation and differentiationCell Proliferation, 2019
- Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlandersJournal of Molecular Medicine, 2017
- The genetic and molecular architecture of phenotypic diversity in sticklebacksPhilosophical Transactions of the Royal Society B: Biological Sciences, 2017
- TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signallingNature Communications, 2017
- TGF‐β Effects on Prostate Cancer Cell Migration and Invasion Require FosBThe Prostate, 2016
- Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathwaysThe International Journal of Biochemistry & Cell Biology, 2016
- DAN (NBL1) Specifically Antagonizes BMP2 and BMP4 and Modulates the Actions of GDF9, BMP2, and BMP4 in the Rat Ovary1Biology of Reproduction, 2012
- TGF‐β signaling and the fibrotic responseThe FASEB Journal, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003